HAEM5:Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes: Difference between revisions
| [pending revision] | [pending revision] |
| Line 84: | Line 84: | ||
|- | |- | ||
|''ETV6'' | |''ETV6'' | ||
|''ETV6::NTRK3'' | |''ETV6::NTRK3''<ref>{{Cite journal|last=Reshmi|first=Shalini C.|last2=Harvey|first2=Richard C.|last3=Roberts|first3=Kathryn G.|last4=Stonerock|first4=Eileen|last5=Smith|first5=Amy|last6=Jenkins|first6=Heather|last7=Chen|first7=I.-Ming|last8=Valentine|first8=Marc|last9=Liu|first9=Yu|date=2017-06-22|title=Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group|url=https://pubmed.ncbi.nlm.nih.gov/28408464|journal=Blood|volume=129|issue=25|pages=3352–3361|doi=10.1182/blood-2016-12-758979|issn=1528-0020|pmc=5482101|pmid=28408464}}</ref> | ||
|Fusion between ETV6 and NTRK3 (5′ to 3′ orientation) | |Fusion between ETV6 and NTRK3 (5′ to 3′ orientation) | ||
| | |t(12;15)(p13;q25) | ||
|<span class="blue-text">EXAMPLE:</span> Rare (Lung adenocarcinoma) | |<span class="blue-text">EXAMPLE:</span> Rare (Lung adenocarcinoma) | ||
|<span class="blue-text">EXAMPLE:</span> T | |<span class="blue-text">EXAMPLE:</span> T | ||